A genotype-directed dose finding study of irinotecan based on UGT1A1 polymorphisms in metastatic colorectal cancer
Not Applicable
- Conditions
- metastatic colorectal cancer
- Registration Number
- JPRN-UMIN000002166
- Lead Sponsor
- kobe University Hospital and Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
PS2,3 prior chemotherapy of irinotecan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adverse events
- Secondary Outcome Measures
Name Time Method